Effects of DHMEQ, a novel nuclear factor-κB inhibitor, on beta cell dysfunction in INS-1 cells

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 433-438

  Saisho, Yoshifumi ^a   Hirose, Hiroshi ^a   Horimai, Chihiro ^a   Miyashita, Kiichi ^a   Takei, Izumi ^a   Umezawa, Kazuo ^b   Itoh, Hiroshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Cell viability; Dehydroxymethylepoxyquinomicin; Glucose stimulated insulin secretion; INS 1 cells; Nuclear factor B; Tumor necrosis factor

Indexed keywords

DEHYDROXYMETHYLEPOXYQUINOMICIN; GLUCOSE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL VIABILITY; DOSE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL;

ANIMALS; BENZAMIDES; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOHEXANONES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE; INSULIN; INSULIN-SECRETING CELLS; INSULINOMA; NF-KAPPA B; PANCREATIC NEOPLASMS; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 43449092909     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-036     Document Type: Article

References (20)

1. Meier JJ, Bhushan A, Butler AE, et al. (2005) Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48: 2221-2228.
2. Eizirik DL, Mandrup-Poulsen T (2001) A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44: 2115-2133.
3. Kahn SE (2001) Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86: 4047-4058.
4. Butler AE, Janson J, Bonner-Weir S, et al. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52: 102-110.
5. Maedler K, Sergeev P, Ris F, et al. (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110: 851-860.
6. Donath MY, Storling J, Maedler K, et al. (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81: 455-470.
7. Ariga A, Namekawa J, Matsumoto N, et al. (2002) Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin. J Biol Chem 277: 24625-24630.
8. Suzuki Y, Sugiyama C, Ohno O, et al. (2004) Preparation and biological activities of optically active dehydroxymethylepoxyquinomicin, a novel NF-kappaB inhibitor. Tetrahedron 60: 7061-7066.
9. Umezawa K (2006) Inhibition of tumor growth by NFkappaB inhibitors. Cancer Sci 97: 990-995.
10. Wakamatsu K, Nanki T, Miyasaka N, et al. (2005) Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells. Arthritis Res Ther 7: R1348-R1359.
11. Kawai T, Hirose H, Seto Y, et al. (2001) Chronic effects of different fatty acids and leptin in INS-1 cells. Diabetes Res Clin Pract 51: 1-8.
12. Tsiotra PC, Tsigos C, Raptis SA (2001) TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int J Obes Relat Metab Disord 25: 1018-1026.
13. Zhang S, Kim KH (1995) TNF-alpha inhibits glucose-induced insulin secretion in a pancreatic beta-cell line (INS-1). FEBS Lett 377: 237-239.
14. De Paula D, Bentley MV, Mahato RI (2007) Effect of iNOS and NF-kappaB gene silencing on beta-cell survival and function. J Drug Target 15: 358-369.
15. Norlin S, Ahlgren U, Edlund H (2005) Nuclear factor-{kappa}B activity in {beta}-cells is required for glucose-stimulated insulin secretion. Diabetes 54: 125-132.
16. Cardozo AK, Heimberg H, Heremans Y, et al. (2001) A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276: 48879-48886.
17. Chang I, Kim S, Kim JY, et al. (2003) Nuclear factor kappaB protects pancreatic beta-cells from tumor necrosis factor-alpha-mediated apoptosis. Diabetes 52: 1169-1175.
18. Liuwantara D, Elliot M, Smith MW, et al. (2006) Nuclear factor-kappaB regulates beta-cell death: a critical role for A20 in beta-cell protection. Diabetes 55: 2491-2501.
19. Papaccio G, Graziano A, D'Aquino R, et al. (2005) A biphasic role of nuclear transcription factor (NF)-kappaB in the islet beta-cell apoptosis induced by interleukin (IL)-1beta. J Cell Physiol 204: 124-130.
20. Hammar EB, Irminger JC, Rickenbach K, et al. (2005) Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J Biol Chem 280: 30630-30637.